$PRVB Deciphera Pharmaceuticals has a cancer drug expected to be approved next year with a potential sales of $700m. That company is valued at $2.5b. We are expecting an approval of a Blockbuster drug here in the next year and half and still valued at $.5b. We will move much higher from current level.
  • 5
  • 6